CA2464615A1 - Composition pharmaceutique comprenant des polypeptides de facteur vii et des polypeptides de facteur v - Google Patents

Composition pharmaceutique comprenant des polypeptides de facteur vii et des polypeptides de facteur v Download PDF

Info

Publication number
CA2464615A1
CA2464615A1 CA002464615A CA2464615A CA2464615A1 CA 2464615 A1 CA2464615 A1 CA 2464615A1 CA 002464615 A CA002464615 A CA 002464615A CA 2464615 A CA2464615 A CA 2464615A CA 2464615 A1 CA2464615 A1 CA 2464615A1
Authority
CA
Canada
Prior art keywords
factor
related polypeptide
factor vii
vii
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002464615A
Other languages
English (en)
Inventor
Rasmus Rojkjaer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk Health Care AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2464615A1 publication Critical patent/CA2464615A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une composition comprenant un polypeptide de facteur VII ou lié au facteur VII et un polypeptide de facteur V ou lié au facteur V et son utilisation dans le traitement des saignements, notamment la réduction du temps de coagulation, le renforcement de l'hémostase ou l'augmentation de la résistance du caillot.
CA002464615A 2001-11-09 2002-11-05 Composition pharmaceutique comprenant des polypeptides de facteur vii et des polypeptides de facteur v Abandoned CA2464615A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101660 2001-11-09
DKPA200101660 2001-11-09
PCT/DK2002/000736 WO2003039584A1 (fr) 2001-11-09 2002-11-05 Composition pharmaceutique comprenant des polypeptides de facteur vii et des polypeptides de facteur v

Publications (1)

Publication Number Publication Date
CA2464615A1 true CA2464615A1 (fr) 2003-05-15

Family

ID=8160820

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002464615A Abandoned CA2464615A1 (fr) 2001-11-09 2002-11-05 Composition pharmaceutique comprenant des polypeptides de facteur vii et des polypeptides de facteur v

Country Status (16)

Country Link
EP (1) EP1446149A1 (fr)
JP (1) JP2005511599A (fr)
KR (1) KR20050043734A (fr)
CN (1) CN1596125A (fr)
AU (1) AU2002340779B2 (fr)
BR (1) BR0213953A (fr)
CA (1) CA2464615A1 (fr)
CZ (1) CZ2004543A3 (fr)
HU (1) HUP0401985A3 (fr)
IL (1) IL161544A0 (fr)
MX (1) MXPA04004304A (fr)
NO (1) NO20042380L (fr)
PL (1) PL370634A1 (fr)
RU (1) RU2004117534A (fr)
WO (1) WO2003039584A1 (fr)
ZA (1) ZA200403271B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378249A1 (fr) 1999-07-14 2001-01-25 Mirella Ezban Utilisation de fviia ou d'un antagoniste de facteur tissulaire tf pour reguler l'expression genique, et migration cellulaire ou chimiotaxie
CN1863908B (zh) 2003-09-09 2010-08-04 诺和诺德医疗保健公司 凝固因子ⅶ多肽
AU2005210175A1 (en) * 2004-02-05 2005-08-18 Novo Nordisk Health Care Ag Use of factor VIIa for treating late complications of trauma
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
ES2399138T3 (es) * 2006-03-16 2013-03-26 Stellaris Pharmaceuticals Aps Tratamiento local con factor VII
EP3065768B1 (fr) * 2013-11-04 2020-09-23 The Regents of the University of California Composition pour l'utilisation dans le traitement ou la prévention d'états associés au saignement ou à l'hypocoagulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0756638T3 (da) * 1994-04-22 2001-07-23 Sanquin Bloedvoorziening Midler til behandling af forstyrrelser i blodkoagulationskaskaden
WO1998058661A1 (fr) * 1997-06-23 1998-12-30 Novo Nordisk A/S UTILISATION DU FVIIa POUR TRAITER DES HEMORRAGIES CHEZ DES PATIENTS PRESENTANT UNE CASCADE DE COAGULATION SANGUINE NORMALE ET UNE FONCTION PLAQUETTAIRE NORMALE
JP2002514433A (ja) * 1998-05-14 2002-05-21 バッテル メモリアル インスティテュート トランスジェニック植物由来ヒト凝血因子

Also Published As

Publication number Publication date
JP2005511599A (ja) 2005-04-28
HUP0401985A2 (hu) 2004-12-28
HUP0401985A3 (en) 2009-03-30
AU2002340779B2 (en) 2007-08-02
PL370634A1 (en) 2005-05-30
ZA200403271B (en) 2004-11-08
CN1596125A (zh) 2005-03-16
IL161544A0 (en) 2004-09-27
KR20050043734A (ko) 2005-05-11
NO20042380L (no) 2004-06-08
MXPA04004304A (es) 2004-08-11
RU2004117534A (ru) 2005-05-10
EP1446149A1 (fr) 2004-08-18
CZ2004543A3 (cs) 2004-08-18
BR0213953A (pt) 2004-08-31
WO2003039584A1 (fr) 2003-05-15

Similar Documents

Publication Publication Date Title
US7125846B2 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
US20050267014A1 (en) Pharmaceutical composition comprising factor VII polypeptides and tranexamic acid
US20070027077A1 (en) Pharmaceutical compositions comprising factor VII polypeptides and factor XI polypeptides
US7078479B2 (en) Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
US20060293241A1 (en) Pharmaceutical composition comprising a factor VII polypeptide and epsilon-aminocaproic acid
US20080069810A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides and TAFI Polypeptides
WO2003039585A1 (fr) Composition pharmaceutique contenant des polypeptides associes au facteur vii et des inhibiteurs de la proteine c
US20030119743A1 (en) Pharmaceutical composition comprising factor VII polypeptides and tissue plasminogen inhibitors
AU2002354846B2 (en) Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
US20060030531A1 (en) Pharmaceutical composition comprising factor VII polypeptide and PAI-1 polypeptide
AU2002354846A1 (en) Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
US20080075709A1 (en) Pharmaceutical Composition Comprising Factor VII Polypeptides And Thrombomodulin Polypeptides
AU2002340779B2 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
AU2002340779A1 (en) Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
AU2002340778B2 (en) Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides
EP1446147A1 (fr) Composition pharmaceutique comprenant des polypeptides du facteur vii et de l'acide tranexamique
EP1446145A1 (fr) Composition pharmaceutique comprenant un polypeptide de facteur vii et un polypeptide tafi
AU2002340778A1 (en) Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides
EP1446154A1 (fr) Composition pharmaceutique comprenant des polypeptides de facteur vii et des polypeptides alpha2-antiplasmines
EP1446151A1 (fr) Composition pharmaceutique comprenant des polypeptides de facteur vii et des polypeptides de thrombomoduline

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued